WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Earnings & Revenue

CORT past earnings growth

How has CORT's earnings growth performed historically?
Company
30.68%
Industry
23.57%
Market
127.59%
CORT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CORT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CORT's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CORT past revenue growth

How has CORT's revenue growth performed historically?
Company
26.51%
Industry
89.94%
Market
19.39%
CORT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CORT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CORT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CORT earnings and revenue history

Current Revenue
$523.5M
Current Earnings
$117.2M
Current Profit Margin
22.4%

CORT Return on Equity

Current Company
24.2%
Current Industry
16.8%
Current Market
28.2%
CORT's Return on Equity (24.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CORT announces earnings.

CORT Return on Assets

Current Company
19.6%
Current Industry
3.2%
CORT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CORT Return on Capital Employed

Current Company
21.67%
Current Industry
-42.4%
CORT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CORT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CORT$523.53M$122.89M$117.19M+15.17%+11.75%
ARWR$35.47M-$432.38M-$470.79M-17.85%N/A
RARE$442.59M-$585.60M-$613.35M+49.64%N/A
DYN$0.00-$255.00M-$257.40MN/AN/A
ACLX$131.66M-$22.77M-$50.54M+635.05%N/A

CORT earnings dates

Next earnings date
Jul 31, 2024

Corcept Therapeutics Earnings & Revenue FAQ

What were CORT's earnings last quarter?

On Invalid Date, Corcept Therapeutics (NASDAQ: CORT) reported Q1 2024 earnings per share (EPS) of $0.27, up 80% year over year. Total Corcept Therapeutics earnings for the quarter were $27.51 million. In the same quarter last year, Corcept Therapeutics's earnings per share (EPS) was $0.15.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.

What was CORT's earnings growth in the past year?

As of Q3 2024, Corcept Therapeutics's earnings has grown 30.68% year over year. This is 7.11 percentage points higher than the US Biotechnology industry earnings growth rate of 23.57%. Corcept Therapeutics's earnings in the past year totalled $117.19 million.

What is CORT's earnings date?

Corcept Therapeutics's earnings date is Invalid Date. Add CORT to your watchlist to be reminded of CORT's next earnings announcement.

What was CORT's revenue last quarter?

On Invalid Date, Corcept Therapeutics (NASDAQ: CORT) reported Q1 2024 revenue of $146.81 million up 38.95% year over year. In the same quarter last year, Corcept Therapeutics's revenue was $105.65 million.

What was CORT's revenue growth in the past year?

As of Q3 2024, Corcept Therapeutics's revenue has grown 26.51% year over year. This is 63.43 percentage points lower than the US Biotechnology industry revenue growth rate of 89.94%. Corcept Therapeutics's revenue in the past year totalled $523.53 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.